Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2014
- 4647-59 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-13-2391 doi
Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung--genetics Disease-Free Survival ErbB Receptors Female Humans Male Middle Aged Mutation--genetics Neoplasm Staging Prognosis Tumor Suppressor Protein p53--genetics